Key Takeaways
- Philip Morris delivered adjusted Q2 EPS of $2.20, surpassing the $2.03 Street estimate
- Second-quarter revenue reached $11.2 billion, marking 10.4% year-over-year growth and a company milestone
- Third-quarter EPS guidance midpoint of $2.225 fell significantly short of the $2.43 Wall Street forecast
- Alternative nicotine products fueled expansion, with revenue climbing 11.7% and shipments advancing 7.5%
- Full-year 2026 adjusted EPS projection of $8.26ā$8.41 remained unchanged
Philip Morris International exceeded analyst expectations for its second-quarter financial results on Wednesday, yet shares tumbled approximately 2.4% following the company’s underwhelming third-quarter outlook.
Philip Morris International Inc., PM
The tobacco giant reported adjusted earnings per share of $2.20, outperforming the consensus estimate of $2.03 by $0.17. Quarterly revenue of $11.2 billion exceeded analyst projections of $10.6 billion.
Second-quarter sales increased 10.4% compared to the prior-year period. This achievement represented the company’s first quarter ever to record net revenues surpassing the $11 billion threshold.
Alternative tobacco products served as the primary catalyst for expansion. This division generated revenue gains of 11.7%, while traditional combustible products saw revenue increase 9.5%.
Robust consumer appetite for Zyn nicotine pouches bolstered performance, particularly after receiving U.S. regulatory clearance. Overall shipment volumes expanded 2.5%, with smoke-free offerings climbing 7.5%.
The global smoke-free division delivered 14.2% revenue expansion, propelled by 8% volume increases. IQOS heated tobacco systems remained the dominant product line within this category.
Management acknowledged certain market challenges. Japan and Poland were specifically identified as regions where IQOS experienced difficulties throughout the quarter.
Adjusted earnings per share advanced 15.2% from $1.91 during the comparable period last year. After removing a positive three-cent currency benefit, the growth rate stood at 13.6%.
Reported diluted EPS registered at $1.80, declining 7.7% year-over-year. This decrease stemmed from a $511 million non-cash impairment charge related to the company’s RBH equity stake.
Third Quarter Forecast Falls Short
Looking ahead to Q3, Philip Morris projected adjusted EPS between $2.20 and $2.25. The $2.225 midpoint significantly trailed the analyst consensus target of $2.43.
This substantial shortfall triggered the stock decline despite otherwise strong quarterly results. PM traded down approximately 2.4% during Wednesday’s morning session.
Annual Forecast Remains Intact
Philip Morris maintained its full-year 2026 adjusted EPS guidance range of $8.26 to $8.41. This outlook represents anticipated growth between 9.5% and 11.5% compared to 2025 levels.
Stripping out foreign exchange impacts, the projection indicates growth of 7.5% to 9.5%. The company reduced its estimated currency benefit to $0.15, down from a prior $0.20 assumption.
Full-year organic net revenue growth is targeted at 5% to 7%. Organic operating income is forecast to expand 7% to 9%.
CEO Jacek Olczak commented that the company “delivered outstanding results in the second quarter, driving net revenues to over $11 billion for the first time with excellent growth across all headline metrics.”
PM shares were changing hands near $187.40 at the time of publication, declining from Tuesday’s closing price of $188.04.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
